Dry Eye News and Research

RSS
Dry eye is one of the most common complaints seen by eye doctors, accounting for nearly one fourth of all office visits. Caused by insufficient tear production or excessive tear evaporation, dry eye can be a mild, episodic feeling of discomfort associated with certain circumstances, such as exposure to dry, hot or windy environments; however, it can also be a chronic medical condition that, if left untreated, may lead to increased risk of infection or visual impairment.
GW scientist awarded $2.8 million NIH grant to continue research on corneal wound healing

GW scientist awarded $2.8 million NIH grant to continue research on corneal wound healing

FDA approval of VisuMax Femtosecond Laser expands surgical treatment options for myopia

FDA approval of VisuMax Femtosecond Laser expands surgical treatment options for myopia

McMaster researchers develop better way to deliver medicine to surface of the eye

McMaster researchers develop better way to deliver medicine to surface of the eye

TSRI researchers find potential way to treat aqueous deficiency dry eye

TSRI researchers find potential way to treat aqueous deficiency dry eye

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Immunotherapy-treated cancer patients may develop rheumatic disorders

Immunotherapy-treated cancer patients may develop rheumatic disorders

FDA approves Raindrop Near Vision Inlay device for patients with presbyopia

FDA approves Raindrop Near Vision Inlay device for patients with presbyopia

Scientists clarify molecular mechanism of Visomitin drug

Scientists clarify molecular mechanism of Visomitin drug

Blueberry component PS may protect against dry eye disease

Blueberry component PS may protect against dry eye disease

New study links cathepsin S protein to tear secretion in Sjogren's syndrome patients

New study links cathepsin S protein to tear secretion in Sjogren's syndrome patients

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Scientists reveal mechanism involved in regulation of lymphangiogenesis

Scientists reveal mechanism involved in regulation of lymphangiogenesis

Stanford researchers develop machine for designing better contact lenses

Stanford researchers develop machine for designing better contact lenses

Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

RegeneRx Biopharmaceuticals announces completion of enrollment for Phase 2b/3 dry eye trial in U.S.

RegeneRx Biopharmaceuticals announces completion of enrollment for Phase 2b/3 dry eye trial in U.S.

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Physician-researchers find link between 'dry eye' and chronic pain syndromes

Physician-researchers find link between 'dry eye' and chronic pain syndromes

Vision of Britain report shows more than 3 in 10 GPs ‘de-skilled’ in diagnosing eye conditions

Vision of Britain report shows more than 3 in 10 GPs ‘de-skilled’ in diagnosing eye conditions

Bio Light's IOPtiMate system approved in Canada for treatment of glaucoma

Bio Light's IOPtiMate system approved in Canada for treatment of glaucoma

Lupuzor may become first non-immunosuppressant therapy for lupus

Lupuzor may become first non-immunosuppressant therapy for lupus